FDA Makes 'Significant Changes' To Drug Registration Rules
Executive Summary
FDA on Sept. 1 issued a final rule that requires firms to electronically submit drug registration information and clarifies who must register their establishments. The final rule goes into effect on Nov. 30, more than 10 years first proposed.
You may also be interested in...
US FDA Drops Plan To Simplify Pharmaceutical Plant Reporting
Industry complained draft guidance would have made manufacturing establishment information harder to report, not easier.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”
EU GMP Annex I Is A Top Priority For EMA While Industry Has Lingering Concerns
Questions about contamination control strategy raised as European Medicines Agency makes EU GMP Annex I revision a top priority in its 2021 work plan.